Tag - RTTR

Developments

Ritter Pharma engages AGP to explore strategic alternatives

Ritter Pharmaceuticals (NASDAQ:RTTR) has engaged Alliance Global Partners as a financial advisor to help the company evaluate strategic alternatives. The company is considering a variety of options, including an...

October 7, 2019

Feature

Ritter Pharma aims to have first FDA-approved treatment for lactose intolerance

By Len Zehr Ritter Pharmaceuticals’ (NASDAQ:RTTR) lead product candidate, RP-G28, which recently entered Phase 3 clinical trials, has the potential to become the first prescription therapy for lactose intolerance, a...

September 4, 2018

Tag - RTTR

Ritter Pharma engages AGP to explore strategic alternatives

Ritter Pharma aims to have first FDA-approved treatment for lactose intolerance

General

More